The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.
MHRA Drug Safety Update - Drug name confusion
MHRA Drug Safety Update - Risperidone and paliperidone: risk of floppy iris syndrome
Central nervous system
LSCMMG is adopting the local decision made prior to April 2013